Stocklytics Platform
Asset logo for symbol NRC
National Research
NRC50
$17.23arrow_drop_up0.70%$0.12
Asset logo for symbol NRC
NRC50

$17.23

arrow_drop_up0.70%
Key Stats
Open$16.82
Prev. Close$17.07
EPS1.12
Next Earnings DateApr 11, 2025
LOWHIGH
Day Range16.91
17.88
52 Week Range16.78
45.49
Ratios
EPS1.12
Fundamentals
Industry average yield2.93%
Last Dividend pay dateJan 10, 2025

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

NRC-
US Healthcare Sector-
US Market-
warning

NRC / Market

NRC lose to the US Market which returned 1.43% over the last twenty four hours.
warning

NRC / Healthcare Sector

NRC lose to the US Healthcare sector which returned 3.54% over the last twenty four hours.

National Research (NRC) Statistics

National Research Corp (NRC) is a company that specializes in providing market research and performance measurement services to the healthcare industry. The company offers a wide range of solutions to help healthcare organizations improve patient experience and quality of care. NRC collects and analyzes data from patients, employees, and physicians to identify areas for improvement and help organizations make informed decisions. With a focus on patient-centered care, NRC's solutions help healthcare providers enhance their reputation and attract new patients. The company's stock performance has been strong, consistently outperforming its sector. NRC's valuation metrics are also favorable, indicating that the company is undervalued compared to its competitors. The stock's revenue per share is impressive, reflecting the company's strong financial performance. NRC's enterprise to EBITDA ratio is favorable, indicating that the company is generating strong operating cash flows. The company's profit margin is also healthy, reflecting its ability to generate profits from its operations. NRC has managed its total debt well, with a low debt-to-equity ratio. This indicates that the company has a strong balance sheet and is not overly reliant on borrowed funds. NRC's gross profit is also impressive, reflecting its ability to generate revenue and manage costs effectively. Overall, NRC is a financially sound company with strong fundamentals and a positive outlook. As the CEO of National Research Corp, [CEO's Name] is responsible for leading the company and driving its growth. With extensive experience in the healthcare industry, [CEO's Name] has been instrumental in shaping NRC's strategies and ensuring its success. Under [CEO's Name]'s leadership, NRC has grown into a market leader and has established itself as a trusted partner for healthcare organizations. With a focus on delivering value to customers and driving innovation, [CEO's Name] continues to lead NRC towards new opportunities and sustained growth.
add National Research to watchlist

Keep an eye on National Research

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has National Research (NRC) stock's performance compared to its sector and the market over the past year?

Over the past year, National Research (NRC) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.21%, National Research has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 50.96%, it has fallen short of the market average. This comparison highlights National Research's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of National Research (NRC) stock?

The PE (Price to Earnings) ratio of National Research (NRC) is currently 15.39. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of National Research (NRC) stock?

The Earnings Per Share (EPS) for National Research (NRC), calculated on a diluted basis, is $1.12. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of National Research (NRC) stock?

The operating margin for National Research (NRC) is 22.29%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of National Research (NRC) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of National Research (NRC) is $43.35M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does National Research (NRC) have?

National Research (NRC) has a total debt of $54.3M. The net debt, which accounts for cash and cash equivalents against the total debt, is $50.17M.

Take Your Investments to a Whole New Level